BACK TO ALL STUDIES
Fort Bragg, NC: Paratrooper Longitudinal Force Protection (PLF) Antibody Study
PRIMARY OBJECTIVE(s)
To determine force readiness through the use of serological and RNA assays for SARS-CoV-2 and other respiratory pathogens.
PRINCIPAL INVESTIGATOR(S)
Sammy Choi
TREATMENT/CLINICAL & LAB INVESTIGATION
No treatment. SARS-CoV-2 antibody testing, neutralizing antibody testing and testing for 22 respiratory pathogens including SARS-CoV-2.
POPULATION
Fort Bragg Soldiers who are members of the XVIII Airborne Corps
FULL NAME OF DIAGNOSTIC TEST
Biofire® Fim Array® Respiratory (RP2plus) Panels, FimArray Bio-agent system (Biofire, Diagnostics, Salt Lake City, Utah)
Lab Used for Diagnostic Test
Womack Army Medical Center, BSL-3 Laboratory, Fort Bragg, NC
Full Name of Serology/Antibody Test
Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM; neutralizing antibodies to be conducted via standard Virus Neutralization Test or high sensitivity and specificity commercial Surrogate Virus Neutralization Test.
Lab Used for Serology/Antibody Test
Womack Army Medical Center, Fort Bragg, NC
Want more information about this study?
study website
